Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
12,219 total articles
MP Materials Corp. Chairman and CEO James H. Litinsky sold 290,000 shares of the company’s common stock under a pre-established Rule 10b5-1 plan, generating roughly $19.21 million. The disposals occurred in two tranches in April 2026 while the shares trade above InvestingPro’s Fair Value and after a 186% year-over-year rally. Several analysts conti…
Lee Kang Jyh, a member of Photronics Inc.'s board, sold 20,000 shares of common stock on April 16, 2026, generating $918,500 at prices between $45.80 and $46.05 per share. The transaction comes as the stock trades near its 52-week high and after Photronics reported fiscal Q1 2026 results that beat analysts' expectations. The company also announced …
Neil Blumenthal, co-chief executive officer of Warby Parker Inc. (WRBY), sold roughly $2.47 million of Class A Common Stock under a Rule 10b5-1 trading plan between April 16 and April 20, 2026. The transactions, undertaken after conversion of Class B shares into Class A shares, occurred at prices between $23.99 and $25.33 per share. The stock has r…
David Leigh Wheeler, General Counsel of Firefly Aerospace Inc. (FLY), exercised employee stock options and sold the resulting 3,766 shares on April 17, 2026. The option exercise cost $8,701 at $2.3106 per share; the subsequent sale generated $169,607 at a weighted average of $45.0366 per share, with transaction prices between $45.00 and $45.06. Bot…
Slide Insurance Holdings Chief Risk Officer Matthew Larson sold 20,000 shares of common stock in April 2026 after exercising fully vested options. The sales, executed under a 10b5-1 trading plan adopted Dec. 4, 2025, generated roughly $384,387 in proceeds. The transactions follow a strong fourth-quarter 2025 performance for the company and recent a…
Clark Joseph Gates, Senior Vice President and President of Optimized LED at Penguin Solutions, sold 5,000 shares of company stock under a pre-established Rule 10b5-1 plan on April 16, 2026, for $134,100. Days later he surrendered 2,288 shares to cover tax withholding tied to restricted stock unit vesting. Penguin Solutions reported second-quarter f…
Yap May Yee, Senior Vice President and Chief Information Officer of Jabil Inc. (NYSE: JBL), sold 1,634 shares of Jabil common stock on April 16, 2026, for a total of $501,220. The sale took place as the shares trade close to a 52-week high, and follows a quarterly financial report that exceeded management guidance midpoints and prompted several ana…
KalVista Pharmaceuticals Chief Financial Officer Brian Piekos sold 1,862 shares on April 17, 2026 in a transaction designed to cover tax withholding from recently settled restricted stock units. The sale, carried out at $20.2163 per share for a total of $37,642, was not discretionary and follows settlement of 6,250 RSUs on April 16, 2026. The compa…
Nicole Sweeny, Chief Commercial Officer of KalVista Pharmaceuticals, sold 1,862 shares of company stock on April 17, 2026, at $20.2163 per share for proceeds of $37,642. The transaction followed the April 16, 2026 vesting and settlement of 6,250 restricted stock units and was executed to satisfy tax withholding obligations rather than as a discreti…
Santiago Subotovsky, a director of Zoom Communications, sold 5,031 shares of Class A common stock on April 16, 2026, for a total of $439,286. The trades, executed under a Rule 10b5-1 plan adopted January 13, 2026, included both direct holdings and shares previously held by the Subotovsky Mann Family Trust, which now holds no Zoom stock. The company…
KalVista Pharmaceuticals Chief Executive Officer Benjamin L. Palleiko executed a sell-to-cover transaction on April 17, 2026, disposing of 9,550 shares worth $193,065 to meet tax withholding obligations tied to vested Restricted Stock Units. The RSU settlement and associated share movement occurred as the company reported robust fourth-quarter fisc…
KalVista Pharmaceuticals' Chief Medical Officer executed a tax-related stock sale worth roughly $54,300 after a tranche of restricted stock units vested. The disposition did not reflect a discretionary sale, and it follows recent corporate updates showing robust Ekterly demand, notable quarterly and annual sales, and interim pediatric trial results…
Steven D. Borges, Executive Vice President of Global Business Units at Jabil Inc. (NYSE: JBL), sold 5,126 shares of company stock on April 17, 2026, for roughly $1.63 million. The sale occurred across multiple trades, at prices between $317.50 and $317.82 and a weighted average of $317.5088 per share. Jabil recently reported a strong fiscal second …
Reddit Chief Operating Officer Jennifer L. Wong disposed of roughly $6.32 million worth of company stock on April 16, 2026, through trades carried out under a Rule 10b5-1 plan. The same day she exercised previously vested options, acquiring 39,167 Class A shares at $5.35 per share. The transactions leave Wong with just over 1.08 million shares dire…
Bicara Therapeutics Chief Executive Officer Claire Mazumdar sold 15,000 shares of company stock for $354,145 on April 20, 2026, under a prearranged Rule 10b5-1 plan. The company has reported strong cash reserves and encouraging clinical data for lead candidate ficerafusp alfa, prompting analyst attention, even as InvestingPro flags potential overva…
Broadwood Partners, L.P. increased its ownership in Insight Molecular Diagnostics (NASDAQ: IMDX) via open-market purchases totaling $652,875 between April 16 and April 20, 2026. The transactions were executed at prices spanning $3.20 to $3.99 per share. Following the buys, Broadwood Partners holds 12,114,700 shares of IMDX and reporting parties hol…
Jayshree Ullal, Arista Networks' CEO and chairperson, sold 350,000 shares on April 16, 2026, through various trusts under Rule 10b5-1 plans she adopted on November 14, 2025. The dispositions totaled approximately $55.76 million at prices between $159.00 and $160.96. The stock has continued to trade higher, near its 52-week peak, while several broke…
WEX Inc. Chief Operating Officer, International Joel Alan Dearborn Jr. sold 3,500 shares of company stock on April 16, 2026, in an automated trade under a Rule 10b5-1 plan. The transaction totaled $612,500 at $175.00 per share. The sale occurs while WEX shares trade close to a 52-week high and ahead of an earnings report scheduled for April 22. Rec…
Two 10% owners of AMREP Corp. (AXR) purchased a combined $69,051 of common stock in mid-April, transactions that leave significant insider holdings intact while the shares trade close to their 52-week high. A recent broker rating shift to Hold was accompanied by a higher price target, and platform analysis flags the stock as slightly overvalued rel…
Christopher C. Swenson, Chief Legal Officer of Nerdy Inc. (NRDY), sold 69,796 Class A shares on April 16, 2026, in an automatic sell-to-cover transaction tied to the vesting of restricted stock units. The trade raised $64,910 at $0.93 per share. Nerdy recently posted fourth-quarter 2025 revenue of $49.1 million, beating analyst estimates, but recei…
John Andrew Paszterko, Chief Operating Officer of Nerdy Inc. (NASDAQ: NRDY), sold 31,788 Class A shares on April 16, 2026, receiving $29,562 as part of a sell-to-cover transaction to satisfy tax withholdings tied to the vesting of 100,000 restricted stock units. The move leaves Paszterko with 1,149,755 total shares and comes amid recent quarterly r…
Seth Yakatan, a director of FITLIFE BRANDS, INC. (NASDAQ:FTLF), purchased 164 shares on January 15, 2026 under a Rule 10b5-1 trading plan for $2,519. The transaction occurred at a weighted average price of $15.3601 per share. Since the buy, the stock has dropped to $8.99 and the company reported large revenue gains in Q4 2025 alongside pressure on …
Akshay Vaishnaw, Scholar Rock’s President of Research & Development, sold 12,246 shares of company stock on April 16, 2026 in a mandated sell-to-cover transaction totaling roughly $607,089. The disposition was tied to the vesting of restricted stock units granted in April 2025. Scholar Rock has also resubmitted its BLA for apitegromab and received …
Scholar Rock Chief Operating Officer Keith Woods completed a non-discretionary sale of 10,220 shares on April 16, 2026, to satisfy tax withholding tied to vested restricted stock units. The transaction, executed under the company’s equity incentive rules, came as the stock traded near a 52-week high and followed a regulatory resubmission for the co…
Scholar Rock Holding Corp's Chief Financial Officer completed a mandated sell-to-cover transaction on April 16, 2026, disposing of 10,410 shares for roughly $516,070 to satisfy tax withholding on recently vested restricted stock units. The move, executed near the stock's 52-week high, was not discretionary, according to the filing. Separately, the …
